resveratrol has been researched along with sphingosine kinase in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (8.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Issuree, PD; Melendez, AJ; Pervaiz, S; Pushparaj, PN | 1 |
| Baran, Y; Kartal, M; Sahin, F; Saydam, G | 1 |
| Gray, AI; Lim, KG; Pyne, NJ; Pyne, S | 1 |
| Hengst, JA; Yun, JK | 1 |
| Abdin, AA | 1 |
| Tian, H; Yu, Z | 1 |
| He, L; Liu, G; Liu, H; Peng, X; Peng, Y; Shi, Y; Wang, Q | 1 |
| Chai, L; Chen, Y; Feng, W; Li, M; Li, S; Liu, P; Shi, W; Wang, J; Wang, Q; Yan, X; Zhai, C; Zhang, Q; Zhu, Y | 1 |
| Hayakawa, F; Ichihara, M; Inoue, C; Ito, T; Kawamoto, Y; Mizutani, N; Murate, T; Nishizawa, Y; Nozawa, Y; Sobue, S; Suzuki, M; Takeuchi, T | 1 |
| Adan, A; Ersöz, NŞ | 1 |
| Deng, YH; Feng, FZ; Gong, WY; Li, SY | 1 |
| Carlucci, CD; Chumanevich, AP; Fuseler, JW; Hui, Y; Nagarkatti, M; Nagarkatti, P; Oskeritzian, CA; Robida, PA; Sajish, M | 1 |
12 other study(ies) available for resveratrol and sphingosine kinase
| Article | Year |
|---|---|
Resveratrol attenuates C5a-induced inflammatory responses in vitro and in vivo by inhibiting phospholipase D and sphingosine kinase activities.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport, Active; Cell Degranulation; Cell Membrane; Chemokines; Chemotaxis, Leukocyte; Complement C5a; Cytokines; Disease Models, Animal; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; In Vitro Techniques; Inflammation; Male; Mice; Mice, Inbred BALB C; Neutrophils; NF-kappa B; Peritonitis; Phospholipase D; Phosphotransferases (Alcohol Group Acceptor); Respiratory Burst; Resveratrol; Stilbenes | 2009 |
Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells.
Topics: Apoptosis; Ceramides; Down-Regulation; Glucosylceramides; Glucosyltransferases; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lysophospholipids; Morpholines; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; RNA, Neoplasm; Sphingosine; Stilbenes; Up-Regulation | 2011 |
Resveratrol dimers are novel sphingosine kinase 1 inhibitors and affect sphingosine kinase 1 expression and cancer cell growth and survival.
Topics: Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; Stilbenes | 2012 |
Sphingosine kinase: a key to solving the 'French Paradox'?
Topics: Antineoplastic Agents; Enzyme Inhibitors; Humans; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; Stilbenes | 2012 |
Targeting sphingosine kinase 1 (SphK1) and apoptosis by colon-specific delivery formula of resveratrol in treatment of experimental ulcerative colitis in rats.
Topics: Animals; Apoptosis; Caspase 3; Chemistry, Pharmaceutical; Colitis, Ulcerative; Colon; DNA Fragmentation; Drug Delivery Systems; Humans; Molecular Targeted Therapy; Organ Specificity; Oxazolone; Peroxidase; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Wistar; Resveratrol; Stilbenes | 2013 |
Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Cell Membrane; Cell Proliferation; Ceramides; Cytosol; Dose-Response Relationship, Drug; Humans; K562 Cells; Leukemia, Myeloid; Lysophospholipids; Phosphotransferases (Alcohol Group Acceptor); Protein Transport; Resveratrol; Signal Transduction; Sphingosine; Stilbenes; Time Factors | 2015 |
Resveratrol Attenuates Adriamycin-Induced Focal Segmental Glomerulosclerosis through C3aR/C5aR- Sphingosine Kinase 1 Pathway.
Topics: Animals; Anti-Inflammatory Agents; Doxorubicin; Fibrosis; Glomerulosclerosis, Focal Segmental; Kidney; Male; Mice; Mice, Inbred BALB C; Phosphotransferases (Alcohol Group Acceptor); Receptor, Anaphylatoxin C5a; Receptors, G-Protein-Coupled; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Hypertension, Pulmonary; Male; Monocrotaline; NF-kappa B; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Stilbenes; Vascular Remodeling | 2018 |
Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes.
Topics: Amino Acid Chloromethyl Ketones; Antioxidants; Apoptosis; Caspase Inhibitors; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Glucosyltransferases; Humans; Inhibitory Concentration 50; Jurkat Cells; K562 Cells; PC-3 Cells; Phosphotransferases (Alcohol Group Acceptor); Resveratrol; Stilbenes; U937 Cells | 2020 |
Resveratrol triggers anti-proliferative and apoptotic effects in FLT3-ITD-positive acute myeloid leukemia cells via inhibiting ceramide catabolism enzymes.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Ceramides; fms-Like Tyrosine Kinase 3; Glucosyltransferases; Humans; Leukemia, Myeloid, Acute; Phosphotransferases (Alcohol Group Acceptor); Resveratrol | 2022 |
Inhibitory Effect of Resveratrol on LPS-induced Glomerular Mesangial Cells Proliferation and TGF-β1 Expression via Sphingosine Kinase 1 Pathway.
Topics: Animals; Cell Proliferation; Cells, Cultured; DNA; Intercellular Signaling Peptides and Proteins; Lipopolysaccharides; Mesangial Cells; Rats; Resveratrol; Transcription Factor AP-1; Transforming Growth Factor beta1 | 2023 |
Resveratrol Protects against Skin Inflammation through Inhibition of Mast Cell, Sphingosine Kinase-1, Stat3 and NF-κB p65 Signaling Activation in Mice.
Topics: Animals; Chemokines; Dermatitis, Atopic; Humans; Inflammation; Mast Cells; Mice; NF-kappa B; Resveratrol; Sphingosine; STAT3 Transcription Factor | 2023 |